Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by jomen1789on Nov 04, 2021 9:11pm
85 Views
Post# 34090007

RE:VMD trades 7 times its 2021 Adj. EBITDA

RE:VMD trades 7 times its 2021 Adj. EBITDAStockfy is a liar and his "Adj. EBITDA in 2021 are estimated at about $30 million (in USD)." is a number conjured out of his butt.

The official news release from Viemed states that after 3 quarters, Adjusted Ebitda is $19.7 million. My number can be verified at this link, I'm not a liar like Stockfy

https://stockhouse.com/news/press-releases/2021/11/01/viemed-healthcare-announces-third-quarter-2021-financial-results

With revenue in Q4 set to be from 0% to 3% higher than Q3, there is no way that Adj. EBITDA of $30 million can be reached. Stockfy just plucked that number out of his rear and thought no one would call him out on it.

Also, RBC's estimate for the FY21 Adj. EBITDA is 26.5 million, you can verify this number here:

https://stockhouse.com/companies/bullboard/t.vmd/viemed-healthcare-inc?postid=34036576

So again, Stockfy takes a nice sounding number out of nowhere, without any source to back it up, then tries to present it as fact.

That's not the first time Stockfy tried to lie like that.

In the link below, Stockfy kept spouting the lie that VMD would have $150 million USD in revenue for 2021.

ISCFA points out that Stockfy's number is false. But Stockfy ignores ISCFA's facts and continues to post the lie that VMD will have $150 million USD revenue in 2021.

https://stockhouse.com/companies/bullboard?symbol=t.vmd&postid=33335733
<< Previous
Bullboard Posts
Next >>